An alternate and converse approach may exploit the presence of TNF in IBC to make this type of breast cancer a suitable candidate for a class of small molecule drugs designed to mimic the function of the second mitochondria-derived activator of caspases (SMAC/Diablo) [49]. The gene discussed is TNF; the disease is breast cancer.